Diansheng Zhong

5PUBLICATIONS
30CO-AUTHORS
Molecular targetsCancer cell biologyStructural properties of condensed matterHealth and ecological risk assessmentCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 12, 2026
Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 study.

Jian-Chun Duan, Jia Zhong, Bo-Yang Sun

|May 30, 2024
CBX4 plays a bidirectional role in transcriptional regulation and lung adenocarcinoma progression.

Ran Zhao, Yanxuan Guo, Linlin Zhang

|Mar 17, 2023
Lung adenocarcinoma associated with cystic airspaces.

Xue Yang, Linlin Zhang, Fanlu Meng

|May 04, 2021
Targeting the EMT transcription factor Snail overcomes resistance to osimertinib in EGFR-mutant non-small cell lung cancer.

Qiong Qin, Xiaoqing Li, Xingmei Liang

|Feb 16, 2021
Safety and efficacy of administering reduced doses of pegylated recombinant human granulocyte-colony stimulating factors in patients treated with cisplatin and etoposide for small cell carcinoma: A retrospective study.

Chang Liu, Ying Hao, Lei Wang

Pageof 1

Frequent Collaborators

1 joint publications

Jian-Chun Duan

1 joint publications

Jia Zhong

1 joint publications

Bo-Yang Sun

1 joint publications

Wen-Hua Zhao